Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The Emerging Role of GLP-1 RAs in Parkinsons Disease Early data show benefits of glucagon-like peptide-1 receptor agonists in halting the progression of this progressive neurologic disorder, which stems from a dopamine deficiency
Others may begin noticing improvements
Lixisenatide therapy in older patients with type 2 diabetes inadequately controlled on their current antidiabetic treatment: the GetGoal-O randomized trial
10.1111/jvim.13970 29
US$ 27.92
US$ 28.51
US$ 24.87
US$ 28.33
.jpg)
US$ 23.66
US$ 28.78
US$ 28.53
US$ 28.53
